drugset / Trial / NCT06750783

The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

NCT06750783

Phase 4 Recruiting 398 enrolled Beijing Tsinghua Chang Gung Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study compares the impact of Xuezhikang and atorvastatin on glucose metabolism to explore the incidence of prediabetes patients developing diabetes after 24 weeks of Xuezhikang use, and by investigating the effect of Xuezhikang on blood glucose fluctuations, discusses the possible mechanisms by which Xuezhikang affects glucose metabolism.

Timeline

Start
2024-12-31
Primary completion
2026-03-31
Completion
2026-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg Oral
Subject Xuezhikang Traditional medicine (herbal / TCM) 600 mg Oral

Indications